Today: Remembering Whitney, Girls and Reality TV, Stars' Awkward Photos
History
This displays a history of all member actions taken on this zine. You can view the details of an action and in some cases reverse it.
Page 1 (of 42)
Title Element Action Member Date View
GlaxoSmithKline Buys Chinese Drugmaker for $70 Million
Article
Auto-Import
strrrrr
History
Current
Rottenstein Law Group Is Encouraged by GlaxoSmithKline’s Settlement of 20,000 Lawsuits Over Its Diabetes Drug Avandia
Article
Auto-Import
charliedavidsonlaw
History
Current
Avandia (Rosiglitazone) increases risk Heart Attack & Stroke
Article
Auto-Import
diabetes
History
Current
Avandia Mediation Nets Settlement for 20,000 Heart Attack Lawsuits
Article
Auto-Import
Cynthia111
History
Current
Settlement Reached for 20,000 Avandia Lawsuits
Article
Auto-Import
PWALaw
History
Current
FDA to Pull Diabetes Drug Avandia From Pharmacy Shelves
Article
Auto-Import
strrrrr
History
Current
Louisiana Lawsuit Filed over Avandia Risks
Article
Auto-Import
PWALaw
History
Current
I want to know what is in the drug that the FDA recalled it is called DIGITEC or digoxin?
Article
Auto-Import
mohammedc
History
Current
GlaxoSmithKline Said to Pay $250 Million to Resolve Avandia Suits
Article
Auto-Import
strrrrr
History
Current
GSK pays US government record $3 billion for illegally marketing drugs (but CEO and executives not held criminally responsible)
Article
Auto-Import
naturalnews1
History
Current
Glaxo May Mediate More Avandia Settlements
Article
Auto-Import
Cynthia111
History
Current
Judge Pushes For Avandia Lawsuit Resolutions
Article
Auto-Import
PWALaw
History
Current
Remaining Avandia Lawsuits May Be Heading to Mediation
Article
Auto-Import
PWALaw
History
Current
Glaxo to Settle Avandia, Other Federal Drug Marketing Investigations
Article
Auto-Import
Cynthia111
History
Current
Glaxo to Settle Avandia, Other Federal Drug Marketing Investigations
Article
Auto-Import
PWALaw
History
Current
More From Zimbio
Zimbio Entertainment
Copyright © 2012 - Zimbio, Inc. Some rights reserved.
Share
. . .
Follow
. . .